VIZZUTTI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.340
EU - Europa 5.023
AS - Asia 3.374
SA - Sud America 464
AF - Africa 96
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 8
Totale 16.365
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.242
RU - Federazione Russa 1.534
IT - Italia 1.060
SG - Singapore 979
CN - Cina 834
PL - Polonia 819
HK - Hong Kong 477
BR - Brasile 370
VN - Vietnam 361
SE - Svezia 359
IE - Irlanda 354
KR - Corea 268
FI - Finlandia 198
DE - Germania 193
FR - Francia 148
UA - Ucraina 106
BD - Bangladesh 103
GB - Regno Unito 100
IN - India 99
AU - Australia 60
CA - Canada 52
JP - Giappone 51
JO - Giordania 49
CH - Svizzera 42
TR - Turchia 39
NL - Olanda 32
AR - Argentina 30
ID - Indonesia 28
MX - Messico 25
IQ - Iraq 23
ES - Italia 18
BE - Belgio 15
NG - Nigeria 15
PK - Pakistan 15
CI - Costa d'Avorio 14
ZA - Sudafrica 14
CO - Colombia 13
EC - Ecuador 11
EG - Egitto 11
CL - Cile 10
RO - Romania 10
VE - Venezuela 10
DZ - Algeria 9
PE - Perù 9
SC - Seychelles 8
KE - Kenya 7
MA - Marocco 7
PH - Filippine 6
PY - Paraguay 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
LT - Lituania 5
MY - Malesia 5
SA - Arabia Saudita 5
XK - ???statistics.table.value.countryCode.XK??? 5
AL - Albania 4
IR - Iran 4
NI - Nicaragua 4
NP - Nepal 4
PT - Portogallo 4
AZ - Azerbaigian 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
LV - Lettonia 3
TW - Taiwan 3
AT - Austria 2
BG - Bulgaria 2
BY - Bielorussia 2
CG - Congo 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EU - Europa 2
GT - Guatemala 2
HU - Ungheria 2
PA - Panama 2
TN - Tunisia 2
UY - Uruguay 2
BF - Burkina Faso 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GN - Guinea 1
GR - Grecia 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LI - Liechtenstein 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
NO - Norvegia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 16.358
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.427
Ashburn 853
Warsaw 817
Singapore 685
Fairfield 665
Hong Kong 393
Chandler 390
Dublin 353
Woodbridge 277
Cambridge 271
Seoul 267
Seattle 263
Houston 237
San Jose 234
Wilmington 226
Milan 210
Hefei 182
Beijing 174
Jacksonville 162
Ann Arbor 126
Los Angeles 117
Florence 114
Ho Chi Minh City 108
Buffalo 100
The Dalles 97
Helsinki 95
Rome 95
Lawrence 90
Altamura 86
Hanoi 86
Lauterbourg 83
Princeton 81
Boardman 65
Moscow 65
New York 64
Council Bluffs 60
Dallas 60
Munich 60
Melbourne 58
Boston 53
São Paulo 46
Bern 42
Medford 42
Mumbai 41
San Diego 36
Naples 33
Tokyo 33
Kent 32
Bologna 27
Paris 26
Shanghai 25
Frankfurt am Main 22
Da Nang 21
Jakarta 21
Izmir 19
Chicago 18
London 18
Turin 18
Turku 18
Phoenix 17
Ankara 16
Lappeenranta 16
Salt Lake City 16
Toronto 16
Abuja 15
Brussels 15
Falls Church 15
Redondo Beach 15
Riverside 15
Abidjan 14
Chennai 14
Montreal 14
Haiphong 13
Columbus 12
Shenzhen 12
Venice 12
Baghdad 11
Figino 11
Norwalk 11
Orem 11
Padua 11
Palermo 11
Dong Ket 10
Guangzhou 10
Sapporo 10
Verona 10
Tianjin 9
Timisoara 9
Yubileyny 9
Amman 8
Andover 8
Atlanta 8
Bengaluru 8
Bremen 8
Cairo 8
Catania 8
City of London 8
Falkenstein 8
Frankfurt Am Main 8
Newark 8
Totale 10.855
Salva come PNG Salva come JPEG
Nome #
Consensus conference on TIPS management: Techniques, indications, contraindications 395
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis 368
Acute on chronic liver failure: From pathophysiology to clinical management. 337
Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature. 313
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study 304
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 268
Anatomy and vascular biology of the cells in the portal circulation 258
Acute viral hepatitis increases liver stiffness values measured by transient elastography 236
THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS 230
Low molecular weight heparin does not increase bleeding and mortality post-endoscopic variceal band ligation in cirrhotic patients 228
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 226
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. 221
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells. 218
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 213
Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells 212
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 209
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice 205
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 203
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 202
ADMA correlates with portal pressure in patients with compensated cirrhosis. 201
Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis. 198
Cellular and molecular basis of fibrogenesis in NASH 196
Farnesyltransferase inhibitor ABT-100 is a potent liver cancer chemopreventive agent 189
Ascites and hepatorenal syndrome 185
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 185
Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status 184
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 183
Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis 178
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C 177
Increased plasma carbon monoxide in patients with viral cirrhosis and hyperdynamic circulation. 177
Alcohol use disorder and liver transplant: new perspectives and critical issues 176
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 175
Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: The missing tool? 171
Characterization of lymphocyte subsets in ascitic fluid and peripheral blood of decompensated cirrhotic patients with chronic hepatitis C and alcoholic liver disease: A pivotal study 170
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. 168
Transient elastography (TE) is more effective for the identification of HCV patients with advanced (F3-F4) rather than significant (F2-F4) liver fibrosis 166
Oxidative stress–induced fibrinogen modifications in liver transplant recipients: unraveling a novel potential mechanism for cardiovascular risk 164
COMPARISON BETWEEN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND LIVER STIFFNESS MEASUREMENT (LSM) IN PATIENTS WITH HCV-RELATED FIBROSIS/CIRRHOSIS 163
End-procedural adherence to recommended hemodynamic targets does not improve the outcome of elective tips in cirrhotic patients 161
Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease 157
Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated Cirrhosis. 157
Transjugular intrahepatic Porto-systemic shunt positively influences the composition and metabolic functions of the gut microbiota in cirrhotic patients 157
Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice 156
Transient elastography (TE) is more effective for the identification of HCV patients with severe (> F3) rather than significant (> F2) liver fibrosis 155
Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis 154
Hepato-systemic gradient of carbon monoxide in cirrhosis. 154
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 149
Super-resolution microscopy reveals an altered fibrin network in cirrhosis: The key role of oxidative stress in fibrinogen structural modifications 149
Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. 148
Update on ascites and hepatorenal syndrome 148
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study 147
Trichobezoar causing gastric outlet obstruction in a patient with trichotillomania 146
Elastography for the non-invasive assessment of liver disease: limitations and future developments 145
Uveitis in autoimmune hepatitis: a case report. 145
Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. 145
Adipokines and liver fibrosis.Eur Rev Med Pharmacol 144
The Metabolic Syndrome and Chronic Liver Disease. 140
n-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis. 139
Clinical evaluation of disease progression in chronic liver disease: towards an integrated system? 137
Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee. 135
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study 135
Reply: Post-TIPS hemodynamic target adherence fails to improve outcomes in cirrhotic patients 134
Performance of ELF Serum Markers in Predicting Fibrosis Stage in Pediatric Non-Alcoholic Fatty Liver Disease. 133
PORTAL HYPERTENSION SECONDARY TO MYELOFIBROSIS A STUDY OF THREE CASES. 133
Fibrosis and cirrhosis reversibility: clinical features and implications 131
Liver Stiffness, a non-invasive marker of liver disease: a core study group report. 131
Management of a complex transjugular intrahepatic portosystemic shunt dysfunction with endotipsitis through rotational thrombectomy 130
EVIDENCE FOR A PATHOGENETIC ROLE OF ASYMMETRIC DIMETHYLARGININE (ADMA) IN CIRRHOTIC PORTAL HYPERTENSION. 130
Hepatic barrage to high-flow, intra-hepatic arteroportal fistulas requiring combined interventional approach 127
Non invasive diagnosis of portal hypertension in cirrhotic patients. 127
Hemodynamic, renal and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 123
Reply to: Does encephalopathy with early onset after TIPS impact on mortality? 122
Liver failure complicating segmental hepatic ischaemia induced by a PTFE-coated TIPS stent. 118
Etiology, management, and outcome of the Budd-Chiari syndrome. 118
Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease. 117
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial 116
Silybin, a component of sylimarin, exert anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells 116
DIURETIC AND NATRIURETIC EFFECTS OF LONG-TERM ALBUMIN INFUSION IN PATIENTS WlTH CIRRHOSIS AND ASCITES: A RANDOMISED CONTROLLED STUDY 116
LIVER STIFFNESS MEASUREMENT (LSM) IS ABLE TO PREDICT SEVERE PORTAL HYPERTENSION IN PATIENTS WITH HCV-RELATED ADVANCED CHRONIC LIVER DISEASE 115
Effect of rituximab on advanced liver disease in patients with HCV-related mixed cryoglobulinemia. 115
Reply 113
Response to letter by R. Mookerjee and R. Jalan [2] 112
Editorial: Looking at Neptune with a binocular 107
Ruolo dell'elastografia transiente nell'identificazione della fibrosi in pazienti con epatopatia cronica HCV correlata 107
Reversible factors in portal hypertension. 106
Impaired sympathetic regulation of cerebral blood flow in patients with cirrhosis of the liver. 106
Paradoxical embolization in TIPS: take a closer look to the heart. 106
 Glycogenic hepatopathy associated with type 1 diabetes mellitus as a cause of recurrent liver damage. 106
Acites due to pericardial cyst 104
Physical activity in liver transplant recipients: a large multicenter study 100
Letter on 'Post-TIPS Overt Hepatic Encephalopathy Increases Long-Term but Not Short-Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large-Scale, Multicentre Real-World' 99
Expanding the severity range of polytetrafluoroethylene-related hepatic outflow occlusion. 97
Small diameter H-graft porta-caval shunt performed at different stages of liver disease 96
Curcumin limits the fibrogenic evolution of experimental steatohepatitis. Lab Invest. 2009 Nov 9. 95
Reply 91
Evaluating the predictive performance of the elderly patient calculator TIPS score in a North American cohort 87
Response to letter by Mookerjee and Jalan 86
Technology insights: non invasive assessment of liver fibrosis by biochemical scores and elastography. 85
Reply to: "Post-TIPS OHE: Are we really making a mountain out of a molehill?" 84
Reply to: “Hepatic encephalopathy and survival after transjugular intra-hepatic portosystemic shunt: Do spontaneous portosystemic shunts matter?” 83
Totale 15.977
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.246
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022595 25 55 38 20 22 28 31 27 34 42 114 159
2022/20231.635 146 267 56 136 119 288 215 94 196 13 49 56
2023/2024576 22 68 93 31 29 56 13 181 8 33 33 9
2024/20254.121 124 402 262 697 1.259 515 65 170 197 97 145 188
2025/20265.868 625 754 502 377 545 249 648 313 412 386 267 790
2026/202710 10 0 0 0 0 0 0 0 0 0 0 0
Totale 16.452